World Class Speakers

 

The World Biosimilar Congress agenda will feature 300+ speakers across multiple streams and co-located events.

Speakers will come from the most successful, innovative and thought-provoking companies from around the world. They will be supported by leading suppliers from the mega tech companies to the latest start-ups who are shaking up the industry.

 

2018 Speakers confirmed to date

 

Jenny Alltoft, Head of Global Biosimilars, Pfizer

Jenny Alltoft at World Biosimilar Congress

Martin Axon, Principal, Occupational Hygienist of Operations for Europe, Safebridge

Martin Axon at World Biosimilar Congress

Dani Bach, Director, Healthcare Ventures, Touchstone Ventures

Dani Bach at World Biosimilar Congress

Jonathan Back, Deputy Director, Project Team Lead, Drug Discovery, Glenmark Pharmaceuticals SA

Jonathan Back at World Biosimilar Congress

Dr Roy Baynes, SVP of Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)

Karoline Bechtold Peters, Senior Strategy & Technology Leader - Pharmaceutical Development, Novartis

Karoline Bechtold Peters at World Biosimilar Congress

Dr Alain Beck, Senior Director, NBEs Analytical Chemistry, Centre d'Immunologie Pierre Fabre

Stephen Beers, Associate Professor, University Of Southampton

Mehdi Benchoufi, Professor, Hopitaux Universitaires Paris Centre

Leigh-Anne Blair, Senior Director - Clinical Operations, Onconova Therapeutics Inc

Leigh-Anne Blair at World Biosimilar Congress

Phil Bland-Ward, Chief Scientific Officer, Crescendo Biologics Ltd

Phil Bland-Ward at World Biosimilar Congress

Dr Ezio Bonvini, CSO, Macrogenics

Louis Boon, Chief Scientific Officer, Bioceros

Ingrid Bourges, Clinical Assessor, Federal Agency for Medicines and Health Products

Ingrid Bourges at World Biosimilar Congress

Frank Brennan, Head of Non-Clinical Toxicology and PK/PD (Immunology), UCB Pharma

Alessandro Brigo, Principal Scientist in Pharma Research and Early Development and Toxicology Project Leader, Roche Pharmaceuticals

Alessandro Brigo at World Biosimilar Congress

Dr Ulrich Brinkmann, Scientific Director, Expert Scientist, Roche

Jack Brown, Senior Principal Scientist, Boehringer Ingelheim Pharmaceuticals Inc

Jack Brown at World Biosimilar Congress

Sebastian Bunk, Research Director, Immunology, Immatics Biotechnologies GmbH

Patrick Burke, Associate Director, Seattle Genetics Inc

Martina Canestraro, Senior Scientist Cell Biology, Immunocore Ltd

Paul Carter, Senior Director and Staff Scientist, Antibody Engineering, Genentech

Sarah Carter, Executive Director, Head of Global Study Operations, Amgen

Sarah Carter at World Biosimilar Congress

Kieran Casey, Business Development Manager, Services, Bioreclamation IVT

Tim Cave, VP-Head Strategic Planning and Digital Practices, Global Medical Affairs, GSK

Tim Cave at World Biosimilar Congress

Brian Champion, CSO, Psioxus Therapeutics Ltd

Brian Champion at World Biosimilar Congress

Deborah Charych, Executive Director, Nektar Therapeutics

Deborah Charych at World Biosimilar Congress

Andre Choo, Principal Scientist and Director, Antibody Discovery, Bioprocessing Technology Institute

Andre Choo at World Biosimilar Congress

Mimi Choon-Quinones, Executive Senior Director, Clinical Operations and Patient Advocacy, Arena Pharmaceuticals

Mimi Choon-Quinones at World Biosimilar Congress

Partha Chowdhury, Senior Director and Head, Antibody Discovery, Sanofi Genzyme

Partha Chowdhury at World Biosimilar Congress

Daniela Cipolletta, Investigator III, Novartis

Jeannick Cizeau, Director of Research, Eleven Biotherapeutics

Nathalie Corvaïa, Managing Director, Institut De Recherche Pierre Fabre

Nathalie Corvaïa at World Biosimilar Congress

Francis Crawley, Good Clinical Practice Alliance (GCPA)

Francis Crawley at World Biosimilar Congress

Prentice Curry, Vice President Quality and Operations, Kite Pharma Inc

Prentice Curry at World Biosimilar Congress

Dr William Dall'Acqua, VP, R&D, MedImmune

Igor D'Angelo, Senior Scientist and Functional Lead, Amgen Inc

Lee Dawson, Senior Scientist, Molecular Pathology Group, Asterand Bioscience

Lee Dawson at World Biosimilar Congress

Emma Dean, Director, Physician And Early Phase Oncology, Astra Zeneca

Emma Dean at World Biosimilar Congress

Dr John Delaney, Executive Director, Amgen Biologics Discovery, Amgen

Madiha Derouazi, Chief Executive Officer, Amal Therapeutics

Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals

Richard DiCicco at World Biosimilar Congress

Claire Dobson, Associate Director of Antibody Discovery and Protein Engineering, MedImmune

Claire Dobson at World Biosimilar Congress

Dr Helena Domingues, Examiner, Joint Cluster Biotechnology, Immunology Directorate, European Patent Office

Dr Helena Domingues at World Biosimilar Congress

Wendel Doubleday, Senior Director of Chemical Development, Seattle Genetics Inc

Wendel Doubleday at World Biosimilar Congress

Roman Drai, Geropharm

Roman Drai at World Biosimilar Congress

Prof Stefan Duebel, Director, Braunschweig University of Technology

Dr Peter Ellmark, Principal Scientist, Immuno-oncology, Alligator Bioscience Ab

Niklas Engler, Head of Technical Development Biologics for Europe, F. Hoffmann-La Roche AG

Niklas Engler at World Biosimilar Congress

Stephan Ewert, Senior Investigator, Novartis Pharma AG

Caroline Feys, Research & Development Operations Innovation (RDO-I) Leader, Jansen

Caroline Feys at World Biosimilar Congress

Kalveer Flora, Specialist Pharmacist Rheumatology & Biosimilars, London North West Healthcare Nhs Trust

Kalveer Flora at World Biosimilar Congress

Agnete Fredriksen, President and Chief Scientific Officer, Vaccibody As

Charlotte French, Executive Director of Portfolio Relationship and Sourcing Management, Astellas Pharma

Per Ola Freskgard, Vice Director & Expert Scientist, Roche Innovation Center Basel

Lothar Germeroth, Senior Vice President and Managing Director, Juno Therapeutics

Lothar Germeroth at World Biosimilar Congress

Dr David Gilham, Vice President of Research and Development, Celyad

Dr David Gilham at World Biosimilar Congress

Jorge González Borroto, Pharmacovigilance Officer/Senior Toxicologist, Ferrer Internacional, S.A.

Jorge González Borroto at World Biosimilar Congress

Niels Grabe, Director, Tissue Imaging and Analysis Center, University of Heidelberg Medical Center

Niels Grabe at World Biosimilar Congress

Eric Halioua, President and Chief Executive Officer, PDC*line pharma SA

Tina Harris, Director Data Management, Amgen Inc

Tina Harris at World Biosimilar Congress

Dr Steffen Hartmann, Global Head Integrated Biologics Profiling, Novartis

Andreas Herrmann, Chief Executive Officer, Valerius Biopharma

Andreas Herrmann at World Biosimilar Congress

Matthew Hewitt, Director, Tumour Immunology & Microenvironment, Bellicum Pharmaceuticals

Stuart Hicks, Associate Director, ImmunoGen Inc

Stuart Hicks at World Biosimilar Congress

Michael Hust, Group Leader, Technical University of Braunschweig

Clare Jacklin, Director, National Rheumatoid Arthritis Society

Clare Jacklin at World Biosimilar Congress

Christopher Jewell, Associate Professor & Damon Runyon-Rachleff Innovator, University of Maryland

Christopher Jewell at World Biosimilar Congress

Liping Jin, Data-Driven Recruitment Lead, F. Hoffmann-La Roche Ltd

Kevin Johnson, Partner, Medicxi

Dr Karin Jooss, Chief Scientific Officer, Gritstone Oncology

Peter Joyce, CEO, Grey Wolf Therapeutics

Meelis Kadaja, Director of Business Development, Icosagen Cell Factory Ltd

Ghassan Karam, Project Manager, W.H.O. I.C.T.R.P.

Robert Kelley, Principal Scientist, Genentech

Robert Kelley at World Biosimilar Congress

James Kent, NHS England

James Kent at World Biosimilar Congress

Shirin Khambata Ford, Executive Director of Oncology Biomarker and Diagnostics Leader, Merck Oncology

Shirin Khambata Ford at World Biosimilar Congress

Houng Kim, head of the strategy and operations division, Celltrion Healthcare

Houng Kim at World Biosimilar Congress

Takashi Kei Kishimoto, Chief Science Officer, Selecta Biosciences Inc

David Klatzmann, Professor, Pierre et Marie Curie University and Medical School

David Klatzmann at World Biosimilar Congress

Roland Kontermann, Professor Of Biomedical Engineering, University of Stuttgart

Dr Jiri Kovarik, Research Investigator, N.I.B.R.

Suzette Kox, Senior Director Of International For Biosimilar Medicines Group, Medicines for Europe A.I.S.B.L.

Suzette Kox at World Biosimilar Congress

Heinz Läubli, Attending Physician, Medical Oncology, University Hospital Basel

Andreas Hougaard Laustsen, Postdoctoral Fellow, Technical University of Denmark

Andy Lee, Senior Vice President and Head of Global Clinical Trial Operations, Merck

Andy Lee at World Biosimilar Congress

Emma Lees, Vice President,, N.I.B.R.

Emma Lees at World Biosimilar Congress

Zhaoyang (Megan) Li, Director, Translational Medicine & Clinical Pharmacology, Sanofi

Chris Lloyd, Senior Scientist, Protein Engineering, Antibody Discovery and Protein Engineering, MedImmune U.K. Ltd

Chris Lloyd at World Biosimilar Congress

Thorsten Lorenz, Group Head of Develop ability Assessment Biologics, Novartis Pharma AG

Thorsten Lorenz at World Biosimilar Congress

Juergen Lukas, Boehringer Ingelheim

Juergen Lukas at World Biosimilar Congress

Reinhold Maeck, Head of Corporation EH&S Regulatory Intelligence, Boehringer Ingelheim

Reinhold Maeck at World Biosimilar Congress

Mark J Mamula, Professor of Medicine Rheumatology, Yale University

Mark J Mamula at World Biosimilar Congress

Dr Ivan Mascanfroni, Senior Scientist, Immunology Biologics, AbbVie

Dr Ivan Mascanfroni at World Biosimilar Congress

Justin Mason-Home, Director, HPAPI Services Limited

Justin Mason-Home at World Biosimilar Congress

Krzysztof Masternak, Head of Biology, NovImmune Sa

Robert Meadowcroft, CEO, The Muscular Dystrophy U.K.

Dr Christoph Merten, Group Leader and Principal Investigator Genome Biology Unit, European Molecular Biology Laboratory

Derek Michael Mason, PhD Candidate, ETH Zurich

Enkelejda Miho, Pioneer, ETH Zurich

Vera Molkenthin, Chief Scientist, Abcheck s.r.o.

Dr M. Anthony Moody, Associate Professor of Paediatrics, Assistant Professor of Immunology, Duke University Medical Center

Hans-Martin Mueller, Director, Biotech Development, Merck

Hans-Martin Mueller at World Biosimilar Congress

Sascha Mundstein, Senior Technologist, Pfizer

Stephen Nabarro, Head of Clinical Operations and Data Management, Centre for Drug Development, Cancer Research UK

Stephen Nabarro at World Biosimilar Congress

Prof Dr Dario Neri, Co-founder, Philogen; Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zurich

Sarfaraz Niazi, Chairman, Professor, Karyo Biologics/UIC

Dr Ahuva Nissim, Reader, William Harvey Research Institute

Kate O'Brien, Albany House Medical Centre

Jennifer O'Callaghan, Clinical Data Sharing Manager, Wellcome Trust

Jennifer O'Callaghan at World Biosimilar Congress

Benjamí Oller-Salvia, EMBO postdoctoral fellow, M.R.C. Laboratory of Molecular Biology

Dr Shane Olwill, Vice President of Development, Pieris Pharmaceuticals

Hardev Pandha, Professor of Medical Oncology, University of Surrey

Hardev Pandha at World Biosimilar Congress

Pinal Patel, Strategic Recruitment Lead, Bristol Myers Squibb

Nora Pencheva, Lead Scientist, Humax-AXL-ADC Program, Genmab

Nicole Piche-Nicholas, Senior Scientist, Pfizer

Nicole Piche-Nicholas at World Biosimilar Congress

Abhinandan Raghavan, Data Scientist, Technology and Functional Leader, Informatics, Novartis Pharma AG

Abhinandan Raghavan at World Biosimilar Congress

Dr Alexey Rak, Head of Bio Structure and Biophysics, Sanofi

Ulrich Rant, Chief Executive Officer, Dynamic Biosensors

Ulrich Rant at World Biosimilar Congress

Dr Fabian Richter, Post-Doctoral Fellow, University of Stuttgart

Theo Rispens, Group Leader, Sanquin

Christoph Roesli, Senior Fellow, Global Drug Development, Novartis Pharma AG

Yun Sanders, Senior scientist, Crescendo Biologics

Andreas Schreiner, Director of Validation, Manufacturing Science and Technology, Novartis Ag

Andreas Schreiner at World Biosimilar Congress

Jonathan Sheffield, Chief Executive Officer, National Institute for Health Research (NIHR)

Darko Skegro, Senior Investigator, Biotherapeutic Technologies, Novartis Institutes for Biomedical Research

Alan K. Smith, Executive Vice President, Technical Operations, Bellicum Pharmaceuticals

Anke Steinmetz, Senior Scientist, Integrated Drug Discovery/Structure, Design & Informatics, Sanofi

Anke Steinmetz at World Biosimilar Congress

Pawel Stocki, Senior Principal Scientist, Ossianix, Inc.

Dr Michael Streit, Sr Director Clinical Research Lead, Janssen

Cian Stutz, Principal Scientist, Antibody Engineering, Glenmark Pharmaceuticals

Lioudmila Tchistiakova, Senior Director of Global Biotherapeutic Technologies, Pfizer

Lioudmila Tchistiakova at World Biosimilar Congress

Thomas Thoma, Head Clinical Trials Supply, Teva Pharmaceuticals

Thomas Thoma at World Biosimilar Congress

Greg Thurber, Assistant Professor of Chemical Engineering, University of Michigan

Greg Thurber at World Biosimilar Congress

Pascal Touchon, Senior Vice President and Global Head Cell & Gene, Novartis

Pascal Touchon at World Biosimilar Congress

Dr Frédéric Triebel, Chief Scientific Officer and Medical Officer, Immutep Ltd

Dr Mihriban Tuna, Vice President, Drug Discovery, F-Star

Peter Van Der Ark, Clinical Scientist, Janssen Pharmaceutical

Laszlo Vasko, Senior Director, Business Technology Leader - Clinical Operations and Innovation, Janssen Pharmaceutical

Wouter Verdurmen, Assistant Professor, Radboud University Medical Center

Dr Alain Vertes, Managing Director, NxR Biotechnologies

Meenu Wadhwa, Section Leader for Cyotkines and Growth Factors Section, NIBSC

Meenu Wadhwa at World Biosimilar Congress

Dr Carl Webster, Principal Scientist, Antibody Discovery and Protein Engineering, MedImmune Cambridge

Dr Martin Welschof, Chief Executive Officer, Opsona Therapeutics Ltd

Dr Jens Würthner, Head of Clinical Development – EU, ADC Therapeutics

Wei Xu, Principal Scientist, Analytical Method Development, Merck Research Laboratories

Tianbo Xu, UCL

Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter Plc

Ildiko Ziegler at World Biosimilar Congress

 

APPLY TO SPEAK


World Biosimilar Congress


Adam Levysohn , Sr Director Market Access Biosimilar, Biogen
Alain Beck
, Senior Director Analytical Chemistry, CIPF and Associate Editor, mAbs
Alain Vertes
, Managing Director, NxR Biotechnologies
Ber Oomen
, Executive Secretary, European Specialist Nurses Organisations
Cecil Nick
, Vice President, Biotechnology, PAREXEL
Divya Chadha Manek
, Head of Commercial Business Development & Marketing, NIHR Clinical Research Network (NIHR CRN)
Gianluca Trifirò
, Department of Biomedical Sciences, Dentistry and Morphological and Functional Images, University of Messina – Italy
Ian Henshaw
, Global Head of Business Operations and Alliance Management, Biogen
Ingrid Schwarzenberger
, Head Global Regulatory Affairs, Sandoz Biopharmaceuticals
Jatinder Harchowal
, Chief Pharmacist / Clinical Director, Medicines Management & Clinical Support Services Business Unit, Pharmacy Dept, The Royal Marsden NHS Foundation Trust
Jonathan Underhill
, Medicines Clinical Adviser, Medicines and Technologies Programme (MTP), NICE
Karsten Roth
, Director Clinical Operations and Pharmacovigilance, Cinfa Biotech GmbH
Philip Ball
, Market Access Manager, NAPP Pharmaceuticals
Ruediger Jankowsky
, Managing Director, Cinfa Biotech GmbH
Shantreddy Soogareddy
, Associate Director External R&D, Dr. Reddy's Laboratories SA.
Steinar Madsen
, Medical Director, Norwegian Medicines Agency
Tim Shea
, Director, Sterne, Kessler, Goldstein & Fox
Uwe Gudat
, Head of Safety, Biosimilars, Merck

 

European Antibody Congress

Alain Beck , Senior Director, NBEs Analytical Chemistry, Pierre Fabre ; Associate Editor, mAbs 
Alexey Rak
, Head of Bio Structure and Biophysics, S anofi R&D
Andreas Hougaard Laustsen
, Postdoctoral Fellow, Tropical Pharmacology Lab, Technical University of Denmark 
Carl Webster, Principal Scientist
, Antibody Discovery and Protein Engineering, MedImmune
Christoph Merten
, Group Leader Microfluidics, European Molecular Biology Laboratory
Darko Skegro
, Senior Investigator, Biotherapeutic and Analytical Technologies, NIBR
Ezio Bonvini
, MD - CSO, Macrogenics
Fabian Richter
, Post-Doc, University of Stuttgart
Frank Brennan
, Senior Director, UCB Celltech
Frank Walsh
, CEO, Ossianix
Helena Domingues
, Examiner, Joint Cluster Biotechnology, Immunology Directorate, European Patent Office
Igor D’Angelo
, Team Lead, Antibody Engineering, Amgen British Colombia 
Ivan Mascanfroni
, Senior Scientist, Immunology Biologics, AbbVie
Janice Reichert
, Executive Director, The Antibody Society ; Editor-in-Chief, mABs
Jens Würthner
, Assistant Vice President, Head of Clinical Development – EU, ADC Therapeutics
Jiri Kovarik
, Research Investigator, Novartis
John Delaney
, Executive Director of Research, Amgen
Krzysztof Masternak
, Head of Biology, NovImmune
Michael Streit
, Senior Director, Clinical Leader Research, Translational Medicine and Early Development, Oncology, Janssen
Nathalie Corvaia
, Director, CIPF, Pierre Fabre
Oliver Spadiut
, Assistant Professor, Integrated Bioprocess Development, TU Wien
Patrick Burke
, Associate Director of Chemistry, Seattle Genetics
Peter Ellmark
, Principal Scientist, Immuno-Oncology, Alligator Bioscience
Peter Senter
, VP, Distinguished Research Fellow, Seattle Genetics
Roy Baynes
, SVP and Head Global Clinical Development, Chief Medical Officer, Merck, Sharp & Dohme (MSD)
Senior representative, AbCheck
Senior representative, Abzena
Senior representative, Acro Biosystems
Senior representative, BioVT
Senior representative, Fujifilm Diosynth Biotechnologies
Senior representative, Icosagen
Senior representative, Isogenica
Senior representative, KBI Biopharma
Stefan Dübel , Director, Department of Biotechnology, Technische Universität Braunschweig
Theo Rispens , Group Leader, Sanquin
Thomas Huber , Senior Investigator II, Technology Leader, Multispecific Modalities, Novartis Instituted for BioMedical Research
Ulrich Brinkmann
, Scientific Director, Roche Pharma Research & Early Development, Roche Innovation Centre Munich
William D’all Acqua
, Vice President of R&D, MedImmune
Zhaoyang (Megan) Li
, Director Clinical Pharmacology, Sanofi

 


World Immunotherapy Congress

Ahuva Nissim , Reader in Antibody and Therapeutic Engineering Biochemical Pharmacology, William Harvey Research Institute, Queen Mary University
Alain Vertes , Managing Director, NxR Biotechnologies
Daniela Cipolletta
, Lab Head, Investigator III, Immuno-Oncology, Novartis
Dario Neri
, Founder, Philogen; Professor of Chemistry and Applied Biology, Swiss Federal Institute of Technology Zurich
Eric Halioua
, President and Chief Executive Officer, PDC*line Pharma
Frédéric Triebel
, Chief Scientific Officer, Chief Medical Officer, Prima BioMed
Hans-Peter Gerber
, CSO, Maverick Therapeutics
Joern Schmitz
, Head, Department of Immunotherapy, Fraunhofer IME
Jose Saro
, Senior Translational Medicine Leader, Roche
M. Anthony Moody
, Associate Professor, Department of Paediatrics, Division of Infectious Diseases, Duke University Medical Centre
Martin Welschof
, Chief Executive Officer, Opsona Therapeutics
Martina Canestraro
, Senior Research Scientist, Immunocore
Roy Baynes
, SVP and Head Global Clinical Development, Chief Medical Officer, Merck, Sharp & Dohme (MSD)
Shane Olwill
, Head of Immuno-Oncology, Pieris Pharmaceuticals 
Sidath Katagampola
, Biomarker Development Sciensist, Centre for Drug Development, Cancer Research UK

 


Clinical Trials


Stephen Nabarro , Head Clinical ops and data, Cancer Research UK
Jonathan Sheffield
, CEO, NIHR
Jim Kremidas,
 Director,  Association of Clinical Research Professionals 
Andy Lee
, Head of Global Clinical Trial Operations, Novartis 
Eileen Dergarabetian
, Head of Medical Information and engagement, Novartis
Joana Claverol
, Clinical Research Unit Manager, Sant Joan de Deu Barcelona Children's Hospital, Research Foundation
Suvodip Shaw
, Global Central Monitoring Operations Manager, Novartis

 


HPAPI World Congress


Wendel Doubleday , Sr Director, Process Research and Development, Seattle Genetics 
Karoline Betchtold Peters
, Senior Strategy & Technology Leader - Pharmaceutical Development, Novartis
Justin Mason Home,
Director, HPAPI Project Services Ltd
Martin Axon
, Principle Occupational Hygienist, SafeBridge  
Marc Abromovitz
, Director, Occupational Health and Hygiene, Novartis  
Ildiko Ziegler
, Distinguished Validation Expert, Gedeon Richter
Reinhold Maeck
, Associate Director Tech-Transfers, Boehringer Ingelheim
Andreas Schreiner
, Director of Validation, Manufacturing Science and Technology, Novartis 
González Borroto
, Pharmacovigilance Officer/Senior Toxicologist, Ferrer Internacional, S.A.Toral 
Toral Mehta
, Head of Industrial Hygiene and Containment, Sandoz 
Jack Brown
, Sr Principle Scientist, Boehringer Ingelheim
Juergen Knoebel
, Senior Advisor - Global Technical Operations Quality Systems/Quality Management, Roche
Alessandro Brigo
, Principal Scientist, Roche

 

 

 

2017 Speakers

 

Tudor Arvinte, President and Chief Executive Officer, Therapeomic Inc

Tudor Arvinte at World Biosimilar Congress

Philip Ball, Market Access Manager, Napp Pharmaceuticals

Philip Ball at World Biosimilar Congress

Fereshteh Barei, Health Economist, LEGOS Paris Dauphine University

Fereshteh Barei at World Biosimilar Congress

Dr Alain Beck, Senior Director, NBEs Analytical Chemistry, Centre d'Immunologie Pierre Fabre

Dr Alain Beck at World Biosimilar Congress

Caroline Boulliat, Immunology, Oncology. Biosimilar Business Unit Head, Amgen Europe Gmbh

Caroline Boulliat at World Biosimilar Congress

Joanna Brougher, Owner & Principal, BioPharma Law Group, PLLC, Biotech, Pharma and Medical Device IP and Corporate Co, BioPharma Law Group PLLC

Joanna Brougher at World Biosimilar Congress

Divya Chadha Manek, Head of Business Development (Commercial), National Institute for Health Research (NIHR)

Divya Chadha Manek at World Biosimilar Congress

Dan Cimpoeru, Board Member, European Cancer Patient Coalition

Dan Cimpoeru at World Biosimilar Congress

Anne Cook, Biologicals Quality Assessor, M.H.R.A.

Anne Cook at World Biosimilar Congress

Margaret Dolan, Regional Pharmacy Procurement Specialist, N.H.S.

Margaret Dolan at World Biosimilar Congress

Pieter Dylst, Senior Manager Market Access, Medicines for Europe

Pieter Dylst at World Biosimilar Congress

Catherine Evans, Business Development Manager for Biopharma, Bruker U.K. Ltd

Catherine Evans at World Biosimilar Congress

Mathias Flume, Head of Drug Department, Kassenarztliche Vereinigung Westfalen-Lippe

Mathias Flume at World Biosimilar Congress

Francois Xavier Frapaise MD, CMO, Merck Biosimilars

Francois Xavier Frapaise MD at World Biosimilar Congress

Uwe Gudat, Head of Safety, Biosimilars, Merck & Cie

Uwe Gudat at World Biosimilar Congress

Jatinder Harchowal, Jatinder Harchowal Chief Pharmacist / Clinical Director, Medicines Management & Clinical Support Services Business Unit, Royal Marsden NHS Foundation Trust

Jatinder Harchowal at World Biosimilar Congress

Ian Henshaw, Head of Business Operations, Biogen

Ian Henshaw at World Biosimilar Congress

Forrest Hu, General Manager of International Business, 3SBio Inc

Forrest Hu at World Biosimilar Congress

Ruediger Jankowsky, Managing Director, Cinfa Biotech

Ruediger Jankowsky at World Biosimilar Congress

Peter Jorgensen, Chief Executive Officer, I.G.L.

Peter Jorgensen at World Biosimilar Congress

Parminder Kaur, CEO, RegPak BioPharma Consulting

Parminder Kaur at World Biosimilar Congress

Tarek Kilani, Former Head of Pharmacy & Continuing Medical Education Coordinator, Emirates French Hospital Llc

Tarek Kilani at World Biosimilar Congress

Martin Knight, Sr. Director, Strategy & Planning, Inflammation, Infectious Disease and General Medicine, Covance

Martin Knight at World Biosimilar Congress

Jenny Koppelkamm, Market Access Director, Takeda

Jenny Koppelkamm at World Biosimilar Congress

William Christopher Lamanna, Laboratory Head of Protein Characterization, Sandoz Inc

William Christopher Lamanna at World Biosimilar Congress

Adam Levysohn, Head of Global Market Access Biogen Biosimilars Business Unit, Biogen

Adam Levysohn at World Biosimilar Congress

Patrick Liu, Vice President of Global Biologics R&D and Head of Biologics, Assays and Technology, Teva Pharmaceuticals U.S.A.

Patrick Liu at World Biosimilar Congress

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Steinar Madsen at World Biosimilar Congress

Márcia Martini Bueno, Institucional Affairs Director, Libbs Pharmaceutica Ltda

Márcia Martini Bueno at World Biosimilar Congress

Victor Lino Mendonça, VP Global Policy & Market Access Europe, Mylan

Victor Lino Mendonça at World Biosimilar Congress

Gopalan Narayanan, VP, Complex Bio, Voisin Consulting Life Sciences (VCLS)

Gopalan Narayanan at World Biosimilar Congress

Cecil Nick, Vice President, PAREXEL

Cecil Nick at World Biosimilar Congress

Ber Oomen, Executive Secretary and Treasurer, ‎European Specialist Nurses Organisations

Ber Oomen at World Biosimilar Congress

Mareike Ostertag, Director Regulatory and Science Policy, Novartis Pharma AG

Mareike Ostertag at World Biosimilar Congress

Michael Reilly, Executive Director, Alliance for Safe Biologic Medicines

Michael Reilly at World Biosimilar Congress

Joaquin Rodrigo, Founder President, BIOSIM Spanish Association of Biosimilars

Joaquin Rodrigo at World Biosimilar Congress

Dr Stacie Ropka, Partner, Axinn

Dr Stacie Ropka at World Biosimilar Congress

Karsten Roth, Director Clinical Operations, Cinfa Biotech

Karsten Roth at World Biosimilar Congress

Ingrid Schwarzenberger, Head of Global Regulatory Affairs Biopharmaceuticals, Sandoz Biopharmaceuticals Gmbh

Ingrid Schwarzenberger at World Biosimilar Congress

Anjan Selz, Vice President – Head of Biosimilars EMEA, Lupin Europe Ltd

Anjan Selz at World Biosimilar Congress

Tim Shea, Director, Sterne Kessler Goldstein And Fox Plc

Tim Shea at World Biosimilar Congress

Shantreddy Soogareddy, Associate Director - External Development R&D (Alliance and Project management), Dr. Reddy's Laboratories Limited

Shantreddy Soogareddy at World Biosimilar Congress

George Stefanov, Marketing Operations Director Biologics, Europe, Mylan

George Stefanov at World Biosimilar Congress

Don Stewart, President and Chief Executive Officer, PlantForm Corporation

Don Stewart at World Biosimilar Congress

Gianluca Trifirò, Assistant Professor of Pharmacology, University of Messina

Gianluca Trifirò at World Biosimilar Congress

Florian Turk, Head of Global Payor Marketing, Sales and Relations, Sandoz

Florian Turk at World Biosimilar Congress

Jonathan Underhill, Associate Director for Medicines Evidence, NICE

Jonathan Underhill at World Biosimilar Congress

Manfred Weiler, Senior Vice President, Medical & Scientific Strategy, INC Research

Manfred Weiler at World Biosimilar Congress

Robert Wojciechowski, Vice President, Global Regulatory Consulting, INC Research/inVentiv Health

Robert Wojciechowski at World Biosimilar Congress

Elena Wolff-Holz, Elena Wolff-Holz, Chair, Biosimilar Medicinal Products Working Party (BMWP), Paul Ehrlich Institut

Elena Wolff-Holz at World Biosimilar Congress

René Wuttke, Bioanalytical Principal Investigator, Global Bioanalytical Services, Celerion Inc.

René Wuttke at World Biosimilar Congress

 

Mark Your Calendars Now!
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October 

Sign Up for Event Updates